Skip to main content

Patents

  • Transgenic non-human models for lipodystrophy and/or PELD
    Aplication No: EP19382828
  • Use of an isolated antigenic peptide derived from protein S100-beta not united to a class II MHC molecule in the prevention, treatment, diagnosis and/or monitoring of Type 1 Diabetes
    Aplication No: ES 2394331 B2
  • Use of Atomic Quantum Clusters (AQCs) in the prevention autoimmune diseases.
    Aplication No: WO2012059571
  • Use of Atomic Quantum Clusters (AQCs) in the prevention of cell proliferative disorders, viral infections and autoimmune diseases.
    Aplication No: EP2457572A1
  • Use of Atomic Quantum Clusters (AQCs) in the prevention of viral infections.
    Aplication No: WO2012059570A1
  • Use of derivates of 6-substituted 3-phenylcoumarins and preparation of new derivates
    Aplication No: WO2010ES70046 20100127
  • Use of p53 inhibitors for reducing food intake and lowering body weight
    Aplication No: WO2012ES70111 20120223
  • Using RSTN for body weight reduction
    Aplication No: ES20080001306 20080506
  • Utilizacion de las yessotoxinas en el tratamiento de procesos alérgicos y asmáticos.
    Aplication No: P200402943